89 related articles for article (PubMed ID: 25497707)
1. In vitro anti-yeast activity of chloramphenicol: A preliminary report.
Joseph MR; Al-Hakami AM; Assiry MM; Jamil AS; Assiry AM; Shaker MA; Hamid ME
J Mycol Med; 2015 Mar; 25(1):17-22. PubMed ID: 25497707
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
Espinel-Ingroff A; Canton E; Gibbs D; Wang A
J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
[TBL] [Abstract][Full Text] [Related]
5. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
6. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
[TBL] [Abstract][Full Text] [Related]
8. The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.
Koselny K; Green J; DiDone L; Halterman JP; Fothergill AW; Wiederhold NP; Patterson TF; Cushion MT; Rappelye C; Wellington M; Krysan DJ
Antimicrob Agents Chemother; 2016 Dec; 60(12):7115-7127. PubMed ID: 27645246
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
10. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
Duval F; Lavarde V
Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Pfaller MA; Hata K; Jones RN; Messer SA; Moet GJ; Castanheira M
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):167-70. PubMed ID: 21696907
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Billack B; Santoro M; Lau-Cam C
Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
Mallié M; Montès B; Reynes J; Bastide JM
Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Chang HC; Chang JJ; Chan SH; Huang AH; Wu TL; Lin MC; Chang TC
J Clin Microbiol; 2001 Apr; 39(4):1328-33. PubMed ID: 11283051
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
Fromtling RA; Yu HP; Shadomy S
Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
18. [The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time].
Cantón E; Pemán J; Romero M; Valentín A; Gobernado M
Rev Esp Quimioter; 2007 Dec; 20(4):433-41. PubMed ID: 18563217
[TBL] [Abstract][Full Text] [Related]
19. Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds.
Yoshida T; Jono K; Okonogi K
Antimicrob Agents Chemother; 1997 Jun; 41(6):1349-51. PubMed ID: 9174197
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility].
Cantón E; Pemán J; Sastre M; Valentín A; Bosch M; Espinel-Ingroff A
Rev Esp Quimioter; 2006 Sep; 19(3):267-74. PubMed ID: 17099795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
